Progestogen-only contraceptive use among breastfeeding women: a systematic review

Contraception

Volumn 82, Issue 1, 2010, Pages 17-37

  Kapp, Nathalie ^a   Curtis, Kathryn ^b   Nanda, Kavita ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

Breastfeeding; Lactation; Postpartum contraception; Progestogen only contraception

Indexed keywords

CHLORMADINONE; CHLORMADINONE ACETATE; DESOGESTREL; ETHINYLESTRADIOL; ETONOGESTREL; FOLLITROPIN; IMMUNOGLOBULIN; LEVONORGESTREL; LUTEINIZING HORMONE; LYNESTRENOL; LYNESTRENOL PLUS MESTRANOL; MEDROXYPROGESTERONE ACETATE; MESTRANOL; MILK PROTEIN; NOMEGESTROL; NORETHISTERONE; NORETHISTERONE ENANTATE; ORAL CONTRACEPTIVE AGENT; PHOSPHORUS; PLACEBO; PROGESTERONE; TESTOSTERONE;

BREAST FEEDING; CHILD DEVELOPMENT; CHILD GROWTH; CHILD HEALTH; CLINICAL TRIAL; CONDOM; CONTRACEPTION; COPPER INTRAUTERINE CONTRACEPTIVE DEVICE; DRUG DOSE COMPARISON; DRUG PELLET; DRUG SAFETY; GASTROENTERITIS; GYNECOMASTIA; HUMAN; IMPLANT; INTRAUTERINE CONTRACEPTIVE DEVICE; LACTATION; MULTIPLE CYCLE TREATMENT; NEUROLOGIC DISEASE; ORAL CONTRACEPTION; OTITIS MEDIA; PARITY; PILL; PNEUMONIA; PUERPERIUM; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; SEIZURE; SIDE EFFECT; SKIN APPENDAGE DISEASE; SKIN DISEASE; SYSTEMATIC REVIEW; URINARY TRACT DISEASE; VAGINA RING; WEIGHT GAIN;

ADULT; BREAST FEEDING; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; FEMALE; GROWTH; HUMANS; INFANT; LACTATION; MALE; MEDLINE; PROGESTINS;

EID: 77953272848     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.02.002     Document Type: Review

References (60)

1. Halderman L.D., and Nelson A.L. Impact of early postpartum administration of progestin-only hormonal contraceptives compared with nonhormonal contraceptives on short-term breast-feeding patterns. Am J Obstet Gynecol 186 (2002) 1250-1256
2. Gray R.H., Campbell O.M., Apelo R., et al. Risk of ovulation during lactation. Lancet 335 (1990) 25-29
3. Labbok M.H., Hight-Laukaran V., Peterson A.E., Fletcher V., von H.H., and Van Look P.F. Multicenter study of the lactational amenorrhea method (LAM): I. Efficacy, duration, and implications for clinical application. Contraception 55 (1997) 327-336
4. Gartner L.M., Morton J., Lawrence R.A., et al. Breastfeeding and the use of human milk. Pediatrics 115 (2005) 496-506
5. Horta B., Bahl R., Martines J., and Victora C. Evidence of the long-term effects of breastfeeding: systematic reviews and meta-analysis (2007), World Health Organization, Geneva, Switzerland
6. Britton C., McCormick F.M., Renfrew M.J., Wade A., and King S.E. Support for breastfeeding mothers. Cochrane Database Syst Rev 1 (2007) CD001141
7. World Health Organization. Global strategy for infant and young child feeding (2003), World Health Organization, Geneva, Switzerland
8. Diaz S. Contraceptive implants and lactation. Contraception 65 (2002) 39-46
9. Schwallie P.C. The effect of depot-medroxyprogesterone acetate on the fetus and nursing infant: a review. Contraception 23 (1981) 375-386
10. Croxatto H.B., Diaz S., Peralta O., et al. Fertility regulation in nursing women .4. Long-term influence of a low-dose combined oral-contraceptive initiated at day 30 postpartum upon lactation and infant growth. Contraception 27 (1983) 13-25
11. Harris R.P., Helfand M., Woolf S.H., et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Preven Med 20 Suppl (2001) 21-35
12. Mohllajee A.P., Curtis K.M., Flanagan R.G., Rinehart W., Gaffield M.L., and Peterson H.B. Keeping up with evidence: a new system for WHO's evidence-based family planning guidance. Am J Preven Med 28 (2005) 483-490
13. Kamal I., Hefnawi F., Ghoneim M., Abdallah M., and Abdel R.S. Clinical, biochemical, and experimental studies on lactation. V. Clinical effects of steroids on the initiation of lactation. Am J Obstet Gynecol 108 (1970) 655-658
14. Karim M., Ammar R., El-mahgoub S., El-ganzoury B., Fikri F., and Abdou I. Injected progestogen and lactation. Br Med J 1 (1971) 200-203
15. Guiloff E., Ibarrapo A., Zanartu J., Toscanin C., Mischler T.W., and Gomezrog C. Effect of contraception on lactation. Am J Obstet Gynecol 118 (1974) 42-45
16. Giner V.J., Cortes V G., Sotelo L.A., and Bondani G. Effect of daily oral administration of 0.350 mg of norethindrone on lactation and on the composition of milk. Ginecol Obstet Mex 40 (1976) 31-39
17. Zanartu J., Aguilera E., and Munoz-Pinto G. Maintenance of lactation by means of continuous low-dose progestogen given post-partum as a contraceptive. Contraception 13 (1976) 313-318
18. Seth U., Yadava H.S., Agarwal N., Laumas K.R., and Hingorani V. Effect of a subdermal silastic implant containing norethindrone acetate on human lactation. Contraception 16 (1977) 383-398
19. Croxatto H.B., Diaz S., Peralta O., et al. Fertility regulation in nursing women. II Comparative performance of progesterone implants versus placebo and copper T. Am J Obstet Gynecol 144 (1982) 201-208
20. Heikkila M., and Luukkainen T. Duration of breast-feeding and development of children after insertion of a levonorgestrel-releasing intrauterine contraceptive device. Contraception 25 (1982) 279-292
21. Diaz S., Peralta O., Juez G., et al. Fertility regulation in nursing women. VI. Contraceptive effectiveness of a subdermal progesterone implant. Contraception 30 (1984) 311-325
22. Jimenez J., Ochoa M., Soler M.P., and Portales P. Long-term follow-up of children breast-fed by mothers receiving depot-medroxyprogesterone acetate. Contraception 30 (1984) 523-533
23. WHO Special Programme of Research Development and Research Training in Human Reproduction. Effects of hormonal contraceptives on milk volume and infant growth. Contraception 30 (1984) 505-522
24. Abdulla K.A., Elwan S.I., Salem H.S., and Shaaban M.M. Effect of early postpartum use of the contraceptive implants, NORPLANT, on the serum levels of immunoglobulins of the mothers and their breastfed infants. Contraception 32 (1985) 261-266
25. Shaaban M.M., Salem H.T., and Abdullah K.A. Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth. Contraception 32 (1985) 623-635
26. Shikary Z.K., Betrabet S.S., Toddywala W.S., Patel D.M., Datey S., and Saxena B.N. Pharmacodynamic effects of levonorgestrel (LNG) administered either orally or subdermally to early postpartum lactating mothers on the urinary levels of follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (T) in their breast-fed male infants. Contraception 34 (1986) 403-412
27. Zacharias S., Aguilera E., Assenzo J.R., and Zanartu J. Effects of hormonal and nonhormonal contraceptives on lactation and incidence of pregnancy. Contraception (1986) 203-213
28. Affandi B., Karmadibrata S., Prihartono J., Lubis F., and Samil R.S. Effect of Norplant on mothers and infants in the postpartum period. Adv Contracept 2 (1986) 371-380
29. McCann M.F., Moggia A.V., Higgins J.E., Potts M., and Becker C. The effects of a progestin-only oral contraceptive (levonorgestrel 0.03 mg) on breast-feeding. Contraception 40 (1989) 635-648
30. Shaaban M.M. Contraception with progestogens and progesterone during lactation. J Steroid Biochem Mol Biol 40 4-6 (1991) 705-710
31. World Health Organization, Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and Research Training in Human Reproduction. Progestogen-only contraceptives during lactation: II. Infant development. Contraception 50 (1994) 55-68
32. World Health Organization Task force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development and Research Training in Human Reproduction. Progestogen-only contraceptives during lactation: I. Infant growth. Contraception 50 (1994) 35-53
33. Abdel-Aleem H., bol-Oyoun E., Shaaban M.M., el-Saeed M., Shoukry M., Makhlouf A., et al. The use of nomegestrol acetate subdermal contraceptive implant, uniplant, during lactation. Contraception 54 (1996) 281-286
34. Sivin I., Diaz S., Croxatto H.B., et al. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD. Contraception 55 (1997) 225-232
35. Hannon P.R., Duggan A.K., Serwint J.R., Vogelhut J.W., Witter F., and DeAngelis C. The influence of medroxyprogesterone on the duration of breast-feeding in mothers in an urban community. Arch Pediatr Adolesc Med 15 (1997) 490-496
36. Diaz S., Zepeda A., Maturana X., Reyes M.V., Miranda P., Casado M.E., et al. Fertility regulation in nursing women : IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant(R) implants, and Copper T 380-A intrauterine devices. Contraception 56 (1997) 223-232
37. Lawrie T.A., Hofmeyr G.J., De Jager M., Berk M., Paiker J., and Viljoen E. A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones. Brit J Obstet Gynaecol 105 (1998) 1082-1090
38. Massai R., Miranda P., Valdes P., Lavin P., Zepeda A., Casado M.E., et al. Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women. Contraception 60 (1999) 9-14
39. Coutinho E.M., Athayde C., Dantas C., Hirsch C., and Barbosa I. Use of a single implant of elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for postpartum nursing women. Contraception 59 (1999) 115-122
40. Bjarnadottir R.I., Gottfredsdottir H., Sigurdardottir K., Geirsson R.T., and Dieben T.O. Comparative study of the effects of a progestogen-only pill containing desogestrel and an intrauterine contraceptive device in lactating women. BJOG 108 (2001) 1174-1180
41. Baheiraei A., Ardsetani N., and Ghazizadeh S. Effects of progestogen-only contraceptives on breast-feeding and infant growth. Int J Gynaecol Obstet 74 (2001) 203-205
42. Massai M.R., Diaz S., Quinteros E., Reyes M.V., Herreros C., Zepeda A., et al. Contraceptive efficacy and clinical performance of Nestorone implants in postpartum women. Contraception 64 (2001) 369-376
43. Schiappacasse V., Diaz S., Zepeda A., Alvarado R., and Herreros C. Health and growth of infants breastfed by Norplant contraceptive implants users: a six-year follow-up study. Contraception 66 (2002) 57-65
44. Diaz S., Herreros C., Juez G., et al. Fertility regulation in nursing women: VII. Influence of NORPLANT levonorgestrel implants upon lactation and infant growth. Contraception 32 (1985) 53-74
45. Shaamash A.H., Sayed G.H., Hussien M.M., and Shaaban M.M. A comparative study of the levonorgestrel-releasing intrauterine system Mirena(R) versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development. Contraception 72 (2005) 346-351
46. Taneepanichskul S., Reinprayoon D., Thaithumyanon P., Praisuwanna P., Tosukhowong P., and Dieben T. Effects of the etonogestrel-releasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants. Contraception 73 (2006) 368-371
47. Reinprayoon D., Taneepanichskul S., Bunyavejchevin S., et al. Effects of the etonogestrel-releasing contraceptive implant (Implanon(R)) on parameters of breastfeeding compared to those of an intrauterine device. Contraception 62 (2000) 239-246
48. Brito M.B., Ferriani R.A., Quintana S.M., Yazlle M.E.H.D., de Sa M.F.S., and Vieira C.S. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception 80 6 (2009) 519-526
49. Truitt S.T., Fraser A.B., Grimes D.A., Gallo M.F., and Schulz K.F. Hormonal contraception during lactation: systematic review of randomized controlled trials. Contraception 68 (2003) 233-238
50. Narducci U., and Piatti N. Use of Depo Provera as a contraceptive in the puerperium. Minerva Ginecol 25 (1973) 107-111
51. Melis G.B., Strigini F., Fruzzetti F., et al. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women. Contraception 23 (1981) 77-88
52. Moggia A.V., Harris G.S., Dunson T.R., Diaz R., Moggia M.S., Ferrer M.A., et al. A comparative study of a progestin-only oral contraceptive versus non-hormonal methods in lactating women in Buenos Aires, Argentina. Contraception 44 (1991) 31-43
53. McEwan J.A., Joyce D.N., Tothill A.U., and Hawkins D.F. Early experience in contraception with a new progestogen. Contraception 16 (1977) 339-350
54. West C.P. The acceptability of a progestagen-only contraceptive during breast-feeding. Contraception 27 (1983) 563-569
55. Massai R., Quinteros E., Reyes M.V., et al. Extended use of a progesterone-releasing vaginal ring in nursing women: a Phase II clinical trial. Contraception 72 (2005) 352-357
56. Thulier D., and Mercer J. Variables associated with breastfeeding duration. J Obstet Gynecol Neonatal Nurs 38 3 (2009) 259-268
57. Nilsson S., Nygren K.G., and Johansson E.D. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women. Am J Obstet Gynecol 129 (1977) 178-184
58. Saxena B.N., Shrimanker K., and Grudzinskas J.G. Levels of contraceptive steroids in breast milk and plasma of lactating women. Contraception 16 6 (1977) 605-613
59. Betrabet S.S., Shikary Z.K., Toddywalla V.S., Toddywalla S.P., Patel D., and Saxena B.N. ICMR Task Force Study on Hormonal Contraception. Transfer of norethisterone (NET) and levonorgestrel (LNG) from a single tablet into the infant's circulation through the mother's milk. Contraception 35 6 (1987) 517-522
60. Shikary Z.K., Betrabet S.S., Patel Z.M., et al. ICMR Task Force Study on Hormonal Contraception. Transfer of levonorgestrel (LNG) administered through different drug delivery systems from the maternal circulation into the newborn infant's circulation via breast milk. Contraception 35 (1987) 477-486